Boston Scientific (NYSE:BSX) reported Q4 2017 earnings this Morning, coming in at $0.34 per share, in-line Wall Street’s estimates of $0.34 per Share. Revenue for the quarter came in at $2.41 billion beating analyst estimates of $2.39 billion Recent Insider Trading for Boston Scientific (NYSE:BSX)
- On 12/29/2018 Michael P. Phalen, EVP, sold 15,835 with an average share price of $25.25 per share and the total transaction amounting to $399,833.75.
- On 1/11/2018 David A Pierce, SVP, sold 8,763 with an average share price of $27.74 per share and the total transaction amounting to $243,085.62.
- On 1/9/2018 David A Pierce, SVP, sold 5,152 with an average share price of $27.00 per share and the total transaction amounting to $139,104.00.
- On 12/29/2017 Michael P Phalen, EVP, sold 15,835 with an average share price of $25.25 per share and the total transaction amounting to $399,833.75.
- On 12/1/2017 Timothy A Pratt, EVP, sold 10,000 with an average share price of $26.04 per share and the total transaction amounting to $260,400.00.
- On 12/1/2017 Valley Gold Master Fund L Sun, Insider, bought 27,431 with an average share price of $0.44 per share and the total transaction amounting to $12,069.64.
Recent Trading for Boston Scientific (NYSE:BSX) Shares of Boston Scientific closed the previous trading session at with 113593 shares trading hands.